Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03508609

Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease

Coronary Microvascular Dysfunction Clinical Trial

Official title:
An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease

Clinical Trial Summary

This clinical trial will explore the safety and effect of GCSF-mobilized autologous ex vivo selected CD34 cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single intracoronary infusion of CLBS16.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03508609
Study type Interventional
Source Caladrius Biosciences, Inc.
Contact
Status Completed
Phase Phase 2
Start date April 19, 2018
Completion date May 5, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT06306066 - Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome
Recruiting NCT05288361 - The DISCOVER INOCA Prospective Multi-center Registry
Terminated NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Recruiting NCT06089031 - Belgian Registry on Coronary Function Testing
Enrolling by invitation NCT06083155 - The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Completed NCT05009667 - A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR)
Active, not recruiting NCT05197361 - Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
Not yet recruiting NCT06332131 - Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Recruiting NCT05825339 - Absolute Flow for Ischemia With No Obstructive Coronary Arteries
Recruiting NCT05294887 - Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Phase 4
Not yet recruiting NCT05790876 - Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculation Dysfunction N/A
Completed NCT04959357 - The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart Disease
Recruiting NCT06393478 - Southeastern Europe Microcirculation Registry
Completed NCT04523168 - Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction N/A
Recruiting NCT05711719 - Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction Phase 2
Recruiting NCT06294730 - COronary Microcirculation and Troponin Elevation in Septic Shock
Recruiting NCT05841485 - COVID-19 Microvascular Evaluation Trial
Recruiting NCT03876223 - Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
Completed NCT05471739 - Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Completed NCT02333591 - Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults Phase 4